Skip to main content

MoneyWorks4Me

Marksans Pharma informs about press release

02 May 2016 Evaluate

Marksans Pharma has informed about a Press Release dated May 02, 2016, titled ‘Marksans Pharma announces USFDA approval for Metformin Hydrochloride Extended-Release (ER) Tablets USP 500mg and 750mg (ANDA 090295)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..